Literature DB >> 28368407

Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.

W Zhai, Y Sun, M Jiang, M Wang, T A Gasiewicz, J Zheng, C Chang.   

Abstract

This corrects the article DOI: 10.1038/sj.gt.3302808.

Entities:  

Year:  2017        PMID： 28368407     DOI： 10.1038/onc.2016.514

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


  4 in total

1.  METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression.

Authors:  Zhuonan Liu; Tianshui Sun; Chiyuan Piao; Zhe Zhang; Chuize Kong
Journal:  J Transl Med       Date:  2021-05-13       Impact factor: 5.531

2.  lncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p/KLF6 axis.

Authors:  Kai Zhu; Chenkui Miao; Ye Tian; Zhiqiang Qin; Jianxin Xue; Jiadong Xia; Shenhao Zhu; Aiming Xu; Jie Yang; Zengjun Wang
Journal:  J Cell Mol Med       Date:  2020-07-30       Impact factor: 5.310

Review 3.  CircRNAs as Novel Biomarkers and Therapeutic Targets in Renal Cell Carcinoma.

Authors:  Yuxia Zhou; Cheng Li; Zhenping Wang; Shuangfeng Tan; Yiqi Liu; Hu Zhang; Xuefeng Li
Journal:  Front Mol Biosci       Date:  2022-02-11

4.  Serum long non-coding RNA LINC00887 as a potential biomarker for diagnosis of renal cell carcinoma.

Authors:  Junjie Xie; Yu Zhong; Rong Chen; Gang Li; Yongwen Luo; Jintao Yang; Zhongwei Sun; Yanzhong Liu; Peipei Liu; Na Wang; Jiaqi An; Chao Li; Yang Song
Journal:  FEBS Open Bio       Date:  2020-07-27       Impact factor: 2.693
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.